Goldman Sachs Kicks Off Earnings Season
Motley Fool Money kicks off earnings season with Goldman Sachs' Q1 2026 results, highlighting $17.2 billion in net revenue (up 14% YoY) and earnings per share of $17.55, beating expectations. The episode breaks down the bank’s mixed performance: equities revenue surged 27% while FICC revenue fell 10%, and the Asset & Wealth Management unit grew 10% despite a dip in private banking fees. Hosts discuss how the rebound in capital markets, high‑profile IPOs, and volatile geopolitical events like the U.S. blockade of Iranian ports are shaping both Goldman’s outlook and broader market themes for the coming earnings season.
3PL Fit: Staying in Your Lane Drives 3PL Growth
In this episode, Kevin Lawton talks with Dave Hariger, CEO of Swift House, about the evolution of his 3PL from a textbook resale operation to a boutique fulfillment provider focused on small brands. Hariger explains how a sudden loss of...
They're Home From the Moon / The Pet Debt Crisis Is Real / Gen Z Thinks AI Is Rotting Their...
The episode covers three main stories: NASA’s Artemis II splashdown, highlighting the historic return of four astronauts and the promise of future lunar missions; the emerging pet‑debt crisis, with veterinary costs up 43% since 2021 and lifetime pet expenses exceeding $50,000,...
Retail Daily Minute | Starbucks Uplifts Chicago Stores, Ahold Delhaize Expands Pay-by-Bank & Edibles.com Enters Physical Retail
The episode spotlights three retail developments: Starbucks' pilot of a cozy, “uplifted” Chicago store under its Back to Starbucks strategy, Ahold Delhaize’s expansion of a pay‑by‑bank payment option across Giant Food and Stop & Shop, and Edibles.com’s launch of a...
The Coveted 1500 Hours
In this episode of Stories About Flying, host Rob recounts his lifelong passion for aviation, from watching planes over Chicago in the 1950s to becoming an airline pilot after decades of ferrying, instructing, and banner‑towing. He interviews Lewis Smith, president...
The Psychedelic Revolution
The episode explores the emerging field of psychedelic therapy, highlighting its potential to treat treatment‑resistant mental health conditions with a few supervised dosing sessions rather than daily medication. Guests Dr. Will Vanderveer and Keith Kurlander explain how the approach combines...
ONC’s Keane Says Government Will Strengthen TEFCA Onboarding to Address Provider Privacy Concerns
In this episode, ONC National Coordinator Tom Keen discusses recent organizational changes at ONC, the dual‑lane approach of TEFCA and CMS‑aligned networks, and how the government is strengthening TEFCA onboarding to address provider privacy concerns. He explains that ONC will...
Inside the RPA's Leadership Development Program
In this episode Tim Fitzpatrick chats with three early‑career nephrologists—Kinjal Shastri, Amandeep (Aman) Raman, and Raman Benaktar—about their recent participation in the Renal Physicians Association’s Leadership Development Program. The fellows explain that the year‑long fellowship pairs them with senior mentors,...
Join Jeremy Aitken, Who Worked in a Covid Vaccination Centre
In this episode, host John Stapleton chats with author Jeremy Aitken about his new book *The Bike* and his varied work experiences, including time on a COVID‑vaccination centre, a butcher shop, and a gym. Aitken reflects on how the pandemic...
One Reporter’s Life-Altering Psychedelic Trip
In this episode of The Daily, host Natalie Kittrow discusses ibogaine—a powerful, illegal psychedelic—with veteran New York Times reporter Robert Draper, who recounts his recent ten‑hour treatment in Tijuana, Mexico. Draper explains ibogaine’s origins, its potential to trigger neuroplasticity and...
When Medical Inquiry and Empiricism Stopped
In this episode, Dr. Peter McCullough—a board‑certified internist, cardiologist, epidemiologist, and former chief academic officer at Ascension Health— discusses his career, his outspoken criticism of the COVID‑19 response, and his concerns about how science has been weaponized as institutional authority. He...
Dr Steven Phillipson and Sean: 'Sarnos' And Sean's Story (#533)
In this episode, clinical psychologist Dr. Steven Phillipson and his patient Sean discuss Sean’s experience with OCD, focusing on the concept of "Sarnos"—psychosomatic symptoms that arise from obsessive worries. Dr. Phillipson explains how exposure and response prevention (ERP) therapy, the...
The Future of Space Manufacturing.
In this episode of T‑Minus, host Maria Varmazis talks with Alistair McGibbon, head of semiconductors at UK‑based SpaceForge, about the company’s breakthrough in growing semiconductor crystals in low‑Earth orbit using plasma‑enhanced chemical vapor deposition. They explain how microgravity yields higher‑quality,...
Meta Pays Up/Impeachment Symposium
In this episode of the Ralph Nader Radio Hour, policy counsel Haley Hinkle of Fair Play discusses recent jury verdicts—$375 million against Meta in New Mexico and a similar ruling against Google/YouTube in California—highlighting how big‑tech platforms knowingly design addictive features...
GPUs Just Got 6x More Valuable. No New Hardware Required.
The episode dives into Google's newly announced TurboQuant breakthrough, a technique that dramatically improves memory efficiency in large language models (LLMs) without requiring new hardware. By enabling lossless compression of LLM processing, TurboQuant makes GPUs effectively six times more valuable,...
